⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIAF News
bioAffinity Technologies, Inc. Common Stock
Form 8-K
sec.gov
BIAF
BIAFW
Form 8-K
sec.gov
BIAF
BIAFW
bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAF
BIAFW
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients
businesswire.com
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test
businesswire.com
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer
businesswire.com
BIAF